EpilepsyGTx is a late preclinical-stage biotech developing cutting-edge gene therapies that will transform the management of focal refractory epilepsy (FRE).
Org chart
Collapse
No reports!
Teams
This company has no teams yet
Offices
This company has no offices yet
